Avalon GloboCare Corp. – NASDAQ:AVCO

Avalon GloboCare Corp. stock price today

$0.526
+0.52
Financial Health
0
1
2
3
4
5
6
7
8
9

Avalon GloboCare Corp. stock price monthly change

-100.00%
month

Avalon GloboCare Corp. stock price quarterly change

-100.00%
quarter

Avalon GloboCare Corp. stock price yearly change

-100.00%
year

Avalon GloboCare Corp. key metrics

Market Cap
5.25M
Enterprise value
51.69M
P/E
-5.15
EV/Sales
41.68
EV/EBITDA
-6.55
Price/Sales
41.15
Price/Book
11.14
PEG ratio
-0.16
EPS
-1.41
Revenue
1.27M
EBITDA
-4.49M
Income
-14.95M
Revenue Q/Q
6.22%
Revenue Y/Y
6.11%
Profit margin
-955.4%
Oper. margin
-711.47%
Gross margin
26.32%
EBIT margin
-711.47%
EBITDA margin
-353.14%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Avalon GloboCare Corp. stock price history

Avalon GloboCare Corp. stock forecast

Avalon GloboCare Corp. financial statements

Avalon GloboCare Corp. (NASDAQ:AVCO): Profit margin
Jun 2023 306.90K -2.54M -828.7%
Sep 2023 331.29K -1.48M -448.27%
Dec 2023 321.32K -9.55M -2973.7%
Mar 2024 314.58K -1.36M -434.7%
Avalon GloboCare Corp. (NASDAQ:AVCO): Debt to assets
Jun 2023 30570584 12.41M 40.62%
Sep 2023 29967181 13.14M 43.86%
Dec 2023 20582536 13.21M 64.2%
Mar 2024 20333236 14.27M 70.23%
Avalon GloboCare Corp. (NASDAQ:AVCO): Cash Flow
Jun 2023 -2.52M -2.01K 2.29M
Sep 2023 -1.34M 30 1.04M
Dec 2023 -748.03K 468.76K 225.00K
Mar 2024 -915.70K 1.21M -273.7K

Avalon GloboCare Corp. alternative data

Avalon GloboCare Corp. (NASDAQ:AVCO): Employee count
Aug 2023 5
Sep 2023 5
Oct 2023 5
Nov 2023 5
Dec 2023 5
Jan 2024 5
Feb 2024 5
Mar 2024 5
Apr 2024 5
May 2024 5
Jun 2024 5
Jul 2024 5

Avalon GloboCare Corp. other data

Avalon GloboCare Corp. (NASDAQ:AVCO): Insider trades (number of shares)
Period Buy Sel
Jun 2019 36000 0
Apr 2020 645161 0
Transaction Date Insider Security Shares Price per share Total value Source
Purchase
LU WENZHAO director, 10 percent owner
Common Stock, $.0001 par value 645,161 $1.55 $1,000,000
Purchase
LU WENZHAO director, 10 percent owner
Common Stock, $.0001 par value 15,000 $1.84 $27,600
Purchase
LU WENZHAO director, 10 percent owner
Common Stock, $.0001 par value 21,000 $2.03 $42,630
Purchase
LU WENZHAO director, 10 percent owner
Common Stock, $.0001 par value 2,000,000 $1 $2,000,000
Purchase
SUKEL STEVEN PHILIP director
Common Stock, $.0001 par value 400 $2.3 $920
Purchase
SUKEL STEVEN PHILIP director
Common Stock, $.0001 par value 600 $2.67 $1,602
Purchase
SUKEL STEVEN PHILIP director
Common Stock, $.0001 par value 500 $1.8 $900
Purchase
SUKEL STEVEN PHILIP director
Common Stock, $.0001 par value 900 $1.8 $1,620
Purchase
SUKEL STEVEN PHILIP director
Common Stock, $.0001 par value 2,700 $1.89 $5,092
Purchase
SUKEL STEVEN PHILIP director
Common Stock, $.0001 par value 1,100 $1.93 $2,118
Monday, 12 December 2022
Proactive Investors
Tuesday, 8 November 2022
Proactive Investors
Thursday, 29 September 2022
PennyStocks
Proactive Investors
Monday, 8 August 2022
Proactive Investors
Thursday, 30 June 2022
Proactive Investors
Wednesday, 25 May 2022
GlobeNewsWire
Wednesday, 18 May 2022
Proactive Investors
Wednesday, 27 April 2022
Proactive Investors
Monday, 14 February 2022
Benzinga
Proactive Investors
Tuesday, 4 January 2022
Proactive Investors
Thursday, 9 December 2021
Proactive Investors
Thursday, 14 October 2021
Proactive Investors
GlobeNewsWire
Thursday, 7 October 2021
Proactive Investors
Benzinga
GlobeNewsWire
Thursday, 30 September 2021
Benzinga
  • What's the price of Avalon GloboCare Corp. stock today?

    One share of Avalon GloboCare Corp. stock can currently be purchased for approximately $0.53.

  • When is Avalon GloboCare Corp.'s next earnings date?

    Unfortunately, Avalon GloboCare Corp.'s (AVCO) next earnings date is currently unknown.

  • Does Avalon GloboCare Corp. pay dividends?

    No, Avalon GloboCare Corp. does not pay dividends.

  • How much money does Avalon GloboCare Corp. make?

    Avalon GloboCare Corp. has a market capitalization of 5.25M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 4.45% to 1.26M US dollars.

  • What is Avalon GloboCare Corp.'s stock symbol?

    Avalon GloboCare Corp. is traded on the NASDAQ under the ticker symbol "AVCO".

  • What is Avalon GloboCare Corp.'s primary industry?

    Company operates in the Real Estate sector and Real Estate - Services industry.

  • How do i buy shares of Avalon GloboCare Corp.?

    Shares of Avalon GloboCare Corp. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Avalon GloboCare Corp.'s key executives?

    Avalon GloboCare Corp.'s management team includes the following people:

    • Dr. David K. Jin M.D., Ph.D. Chief Executive Officer, Pres & Director(age: 57, pay: $360,000)
    • Ms. Luisa Ingargiola Chief Financial Officer(age: 61, pay: $350,000)
    • Ms. Meng Li Chief Operating Officer, Sec. & Director(age: 47, pay: $340,000)
  • How many employees does Avalon GloboCare Corp. have?

    As Jul 2024, Avalon GloboCare Corp. employs 5 workers.

  • When Avalon GloboCare Corp. went public?

    Avalon GloboCare Corp. is publicly traded company for more then 9 years since IPO on 22 Feb 2016.

  • What is Avalon GloboCare Corp.'s official website?

    The official website for Avalon GloboCare Corp. is avalon-globocare.com.

  • Where are Avalon GloboCare Corp.'s headquarters?

    Avalon GloboCare Corp. is headquartered at 4400 US Highway 9 Ste 3100, Freehold, NEW JERSEY.

  • How can i contact Avalon GloboCare Corp.?

    Avalon GloboCare Corp.'s mailing address is 4400 US Highway 9 Ste 3100, Freehold, NEW JERSEY and company can be reached via phone at +1 646 762 4517.

Avalon GloboCare Corp. company profile:

Avalon GloboCare Corp.

avalon-globocare.com
Exchange:

NASDAQ

Full time employees:

5

Industry:

Real Estate - Services

Sector:

Real Estate

Avalon GloboCare Corp., together with its subsidiaries, owns and operates commercial real estate properties in the United States and the People's Republic of China. The company offers medical related consulting services, including research studies, executive education, daily online executive briefings, tailored expert advisory services, and consulting and management services in the areas of immunotherapy and second opinion/referral services. Its leading candidates are AVA-001, an anti-CD19 CAR-T, which has completed first-in-human clinical trial for relapsed/refractory (R/R) B-cell lymphoblastic leukemia; and AVA-011 that has completed pre-clinical laboratory studies and undergoing IND-enabling process development stage to generate cGMP-grade AVA-011 CAR-T cells. It is also developing RNA-based FASH-CARTM cell therapy platform. In addition, the company develops avalon clinical-grade tissue-specific exosome (ACTEX); offers therapeutic and diagnostic targets utilizing QTY-code protein design technology with Massachusetts Institute of Technology (MIT), including using the QTY code protein design technology for development of a hemofiltration device to treat Cytokine Storm; and provides co-development of next generation, transposon-based, multi-target CAR-T, CAR-NK, and other immune effector cell therapeutic modalities with Arbele Limited. Further, it has strategic partnership with the University of Natural Resources and Life Sciences in Vienna and Austria to develop an S-layer vaccine that could be administered by an intranasal or oral route against SARS-CoV-2 and coronavirus that causes COVID-19 disease; and develops Avalon Cell and Avalon Rehab, as well as promotes standardization related to exosome industry. The company is headquartered in Freehold, New Jersey.

4400 US Highway 9 Ste 3100
Freehold, NEW JERSEY 07728

CIK: 0001630212
ISIN: US05344R1041
CUSIP: 05344R104